Clinical trial
A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax
NCT06365073 is registered in ClinicalTrials.gov with Qin Ning as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax
- Lead sponsor
- Qin Ning
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 13, 2024
- Completion date
- December 31, 2024
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.